HYBRID EVENT: You can participate in person at Los Angeles, CA, USA or Virtually from your home or work.

Qun Wang

 

Qun Wang

The First Hospital of Jilin University
China

Abstract Title: Impact of Rising Obesity on Predominant Female Infertility Factors in IVF Patients at the First Hospital of Jilin University

Biography:

Dr. Qun Wang is an attending physician and specialist in reproductive medicine at the Center for Reproductive Medicine, The First Hospital of Jilin University. With extensive experience in assisted reproductive technology (ART) and a focus on the impact of lifestyle factors on infertility, Dr. Wang research includes studies on metabolic influences in reproductive health. Dr. Wang has contributed to numerous clinical studies and published extensively in the field of reproductive medicine.

Research Interest:

Over the past decade, obesity rates in China have increased significantly, potentially influencing the primary factors contributing to infertility among women undergoing in vitro fertilization (IVF) treatment. This retrospective study investigates the distribution of female infertility factors among couples receiving IVF at the Center for Reproductive Medicine, The First Hospital of Jilin University, in the years 2015 and 2023.An examination of data from 2015 reveals that tubal and endometrial factors were initially the primary indications for IVF treatment. However, by 2023, ovulatory disorders, particularly polycystic ovary syndrome (PCOS), had become the leading contributors to the need for IVF treatment. This transition is closely linked to the increasing prevalence of obesity, which exacerbates insulin resistance and diminishes the effectiveness of traditional ovulation induction treatments. As a result, the reduced success rates of these standard therapies have led to a higher number of patients resorting to in vitro fertilization (IVF), thereby escalating both the burden on patients and healthcare expenditures. This study highlights the critical necessity to address obesity and associated metabolic disorders in women of reproductive age, as targeted interventions have the potential to enhance fertility outcomes and decrease reliance on expensive assisted reproductive technologies.